Clinical research for biomarkers in patients with drug-induced lung injury and their clinical significance

Clinical research for biomarkers in patients with drug-induced lung injury and their clinical significance - Clinical research for biomarkers in patients with drug-induced lung injury

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033951

Enrollment

Registered

2018-08-29

Start date

2018-08-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cases of suspected drug-induced lung injury and performed bronchoalveolar lavage for diagnostic

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1: Patients who are suspected of drug-induced lung injury and undergo bronchoalveolar lavage for diagnostic purposes 2: Cases in which written consent was obtained to the principal (or substitute) 3: Age over 20 years old 4: Gender is unnecessary 5: Hospitalization / Outpatient is not required

Exclusion criteria

Exclusion criteria: Cases in which research researcher or shared medical doctor deemed inappropriate for participation in this study

Design outcomes

Primary

Measure	Time frame
Rate of tumor infiltrating lymphocytes in bronchoalveolar lavage fluid in patients with drug-induced lung injury by immunity checkpoint inhibitors	—

Secondary

Measure	Time frame
Relationship with patient background and various examination items	—

Countries

Japan

Contacts

Public ContactMasahiro Tahara

University of Occupational and Environmental Health Department of Respiratory Medicine

tahara-masahiro@med.uoeh-u.ac.jp093-691-7453

Outcome results